Preferred Name | testosterone enanthate | |
Synonyms |
Andro LA Primosteston Delatestryl Androtardyl Testo-Enant Everone Testinon Testate |
|
Definitions |
A long-acting intramuscular form of the androgen testosterone. Testosterone inhibits gonadotropin secretion from the pituitary gland and ablates estrogen production in the ovaries, thereby decreasing endogenous estrogen levels. In addition, this agent promotes the maintenance of male sex characteristics and is indicated for testosterone replacement in hypogonadal males, delayed puberty, and metastatic mammary cancer. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1247" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1247" NCI Thesaurus) |
|
ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000795022 |
|
altLabel |
Andro LA Primosteston Delatestryl Androtardyl Testo-Enant Everone Testinon Testate |
|
CAS Registry |
315-37-7 |
|
cui |
C0720317 C1515322 C1515321 C0733489 C0733492 C0076189 C0719723 C1515319 C1515320 |
|
DATE FIRST PUBLISHED |
2018-10-01 |
|
Date last modified |
2018-10-01 |
|
definition |
A long-acting intramuscular form of the androgen testosterone. Testosterone inhibits gonadotropin secretion from the pituitary gland and ablates estrogen production in the ovaries, thereby decreasing endogenous estrogen levels. In addition, this agent promotes the maintenance of male sex characteristics and is indicated for testosterone replacement in hypogonadal males, delayed puberty, and metastatic mammary cancer. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1247" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1247" NCI Thesaurus) |
|
LT |
TRD |
|
NCI ID |
C1247 |
|
notation |
CDR0000795022 |
|
NSC Code |
17591 |
|
ORIG STY |
Drug/agent |
|
prefLabel |
testosterone enanthate |
|
tui |
T125 T109 T121 |